Bio-Gene Technology Limited

ASX:BGT 株式レポート

時価総額:AU$10.1m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Bio-Gene Technology マネジメント

マネジメント 基準チェック /04

Bio-Gene Technology'sの CEO はTim Groganで、 Aug2023年に任命され、 の在任期間は 1 年未満です。 は、会社の株式の0.03%を直接所有しており、その価値はA$ 2.98K 。経営陣と取締役会の平均在任期間はそれぞれ0.8年と1.2年です。

主要情報

Tim Grogan

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権0.03%
経営陣の平均在職期間less than a year
取締役会の平均在任期間1.2yrs

経営陣の近況

Recent updates

We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Feb 22
We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Oct 25
Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Jun 20
Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

Apr 28
Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

Jan 11
What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

CEO(最高経営責任者

Tim Grogan

less than a year

在職期間

Mr. Timothy Owen Grogan, LLB, B.Sc., also known as Tim, serves as Managing Director, Chief Executive Officer & Director of Bio-Gene Technology Limited since August 28, 2023. He serves as a Director of Cons...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Peter May
Executive Director of Research & Development and Executive Director6.4yrsAU$246.25k0.91%
A$ 92.1k
Timothy Grogan
MD, CEO & Directorless than a yearデータなし0.030%
A$ 3.0k
Edmond Tern
CFO & Joint Company Secretaryless than a yearデータなしデータなし

0.8yrs

平均在職期間

経験豊富な経営陣: BGTの経営陣は 経験豊富 とはみなされません ( 0.8年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Peter May
Executive Director of Research & Development and Executive Director9.1yrsAU$246.25k0.91%
A$ 92.1k
Timothy Grogan
MD, CEO & Directorless than a yearデータなし0.030%
A$ 3.0k
Douglas Rathbone
Adviser to the Board6.5yrsデータなしデータなし
Peter Beetham
Member of Scientific Advisory Board1.2yrsAU$45.50k0.030%
A$ 3.0k
Andrew Guthrie
Non-Executive Director3.2yrsAU$57.62k0.13%
A$ 13.4k
Catherine Hill
Member of the Scientific Advisory Board6.3yrsデータなしデータなし
Neil Anderson
Member of Scientific Advisory Boardno dataデータなしデータなし
Andrew Bartholomaeus
Member of Scientific Advisory Boardno dataデータなしデータなし
Huong Soo Ding
Non-Executive Chairman1.1yrsAU$6.97k0.060%
A$ 6.1k
Christopher Ramsay
Non-Executive Director1.1yrsAU$6.97kデータなし
Chris Ramsey
Non Executive Directorless than a yearデータなし0.059%
A$ 6.0k

1.2yrs

平均在職期間

経験豊富なボード: BGTの 取締役会経験豊富 ではない ( 1.2年の平均在任期間) ため、新しい取締役会が必要であると考えられます。